Solaris Resources (CVE:SLS) Trading Down 2.7%

Solaris Resources Inc. (CVE:SLS)’s share price was down 2.7% during trading on Friday . The company traded as low as C$5.95 and last traded at C$6.15. Approximately 53,313 shares traded hands during mid-day trading, a decline of 60% from the average daily volume of 132,199 shares. The stock had previously closed at C$6.32.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on SLS. National Bank Financial raised Solaris Resources to a “strong-buy” rating in a report on Monday, June 10th. HC Wainwright raised shares of Solaris Resources to a “strong-buy” rating in a research note on Monday, August 12th. Finally, Maxim Group upgraded shares of Solaris Resources to a “strong-buy” rating in a research report on Wednesday, July 3rd.

Solaris Resources Stock Down 2.7 %

The company’s 50 day simple moving average is C$6.15.

Solaris Resources (CVE:SLS) last announced its quarterly earnings data on Thursday, August 8th. The company reported C($0.16) EPS for the quarter.

Solaris Resources Company Profile

SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.